HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-100

Clinical outcomes of female breast cancer according to BRCA mutation status. Cancer epidemiology 2017 Jun 49 128-137. Cronin-Fenton Deirdre P, Kjærsgaard Anders, Nørgaard Mette, Pedersen Inge Søkilde, Thomassen Mads, Kaye James A, Gutierrez Lia, Telford Claire, Lewis Jan, Tyczynski Jerzy E, Sørensen Henrik To
High frequency of the recurrent c.1310_1313delAAGA BRCA2 mutation in the North-East of Morocco and implication for hereditary breast-ovarian cancer prevention and control. BMC research notes 2017 Jun 10 (1): 188. Laarabi Fatima-Zahra, Ratbi Ilham, Elalaoui Siham Chafai, Mezzouar Loubna, Doubaj Yassamine, Bouguenouch Laila, Ouldim Karim, Benjaafar Noureddine, Sefiani Abdelaz
Is Low FMR1 CGG Repeat Length in Males Correlated with Family History of BRCA-Associated Cancers? An Exploratory Analysis of Medical Records. Journal of genetic counseling 2017 Jun . Adamsheck Hallee C, Petty Elizabeth M, Hong Jinkuk, Baker Mei W, Brilliant Murray H, Mailick Marsha
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. The New England journal of medicine 2017 Jun . Robson Mark, Im Seock-Ah, Senkus El?bieta, Xu Binghe, Domchek Susan M, Masuda Norikazu, Delaloge Suzette, Li Wei, Tung Nadine, Armstrong Anne, Wu Wenting, Goessl Carsten, Runswick Sarah, Conte Pierfran
Young Israeli women with epithelial ovarian cancer: prevalence of BRCA mutations and clinical correlates. Journal of gynecologic oncology 2017 Jun . Helpman Limor, Zidan Omri, Friedman Eitan, Kalfon Sarit, Perri Tamar, Ben-Baruch Gilad, Korach Jac
A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 996-1004. Monk B J, Brady M F, Aghajanian C, Lankes H A, Rizack T, Leach J, Fowler J M, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher E M, Anderson K S, Gottardo R, Bryan J K, Newkirk M, Manjarrez K L, Mannel R S, Hershberg R M, Coukos
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers. Familial cancer 2017 May . Gabaldó Barrios Xavier, Sarabia Meseguer Mª Desamparados, Marín Vera Miguel, Sánchez Bermúdez Ana Isabel, Macías Cerrolaza José Antonio, Sánchez Henarejos Pilar, Zafra Poves Marta, García Hernández Mª Rosario, Cuevas Tortosa Encarna, Aliaga Baño Ángeles, Castillo Guardiola Verónica, Martínez Hernández Pedro, Tovar Zapata Isabel, Martínez Barba Enrique, Ayala de la Peña Francisco, Alonso Romero José Luis, Noguera Velasco José Antonio, Ruiz Espejo Francis
Next-Generation Sequencing Reveals a Nonsense Mutation (p.Arg364Ter) in MRE11A Gene in an Indian Patient with Familial Breast Cancer. Breast care (Basel, Switzerland) 2017 May 12 (2): 114-116. Sharma Bhai Pratibha, Sharma Deepak, Saxena Renu, Verma Ishwar
Analysis Suggests Wider Use for PARP Inhibitors. Cancer discovery 2017 Apr . Authors are not available
Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial. Breast (Edinburgh, Scotland) 2017 Apr 34 18-23. Ghouadni Amal, Delaloge Suzette, Lardelli Pilar, Kahatt Carmen, Byrski Tomasz, Blum Joanne L, Gonçalves Anthony, Campone Mario, Nieto Antonio, Alfaro Vicente, Cullell-Young Martin, Lubinski J
Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer. Gynecologic oncology 2017 Apr . Bookman Michael A, Tyczynski Jerzy E, Espirito Janet L, Wilson Thomas W, Fernandes Ancilla
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay. Oncology reports 2017 Mar 37 (3): 1379-1386. Baert Annelot, Depuydt Julie, Van Maerken Tom, Poppe Bruce, Malfait Fransiska, Van Damme Tim, De Nobele Sylvia, Perletti Gianpaolo, De Leeneer Kim, Claes Kathleen B M, Vral An
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers. Breast cancer research and treatment 2017 Mar . Krammer Julia, Pinker-Domenig Katja, Robson Mark E, Gönen Mithat, Bernard-Davila Blanca, Morris Elizabeth A, Mangino Debra A, Jochelson Maxine
The Spectrum of BRCA Mutations and Characteristics of BRCA-associated Breast Cancers in China: Screening of 2991 Patients and 1043 Controls by Next-Generation Sequencing. International journal of cancer 2017 Mar . Lang Guan-Tian, Shi Jin-Xiu, Hu Xin, Zhang Chen-Hui, Shan Ling, Song Chuan-Gui, Zhuang Zhi-Gang, Cao A-Yong, Ling Hong, Yu Ke-Da, Shan Li, Sun Meng-Hong, Zhou Xiao-Yan, Huang Wei, Shao Zhi-Mi
BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients. Gynecologic oncology 2017 Feb . Eoh Kyung Jin, Park Ji Soo, Park Hyung Seok, Lee Seung-Tae, Han Jeongwoo, Lee Jung-Yun, Kim Sang Wun, Kim Sunghoon, Kim Young Tae, Nam Eun
High-risk epithelial ovarian cancer patients for hereditary ovarian cancer. The journal of obstetrics and gynaecology research 2017 Feb . Chirasophon Seksit, Manchana Tarinee, Teerapakpinyo Chinacho
Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. British journal of cancer 2017 Feb . Golan Talia, Sella Tal, O'Reilly Eileen M, Katz Matthew H G, Epelbaum Ron, Kelsen David P, Borgida Ayelet, Maynard Hannah, Kindler Hedy, Friedmen Eitan, Javle Milind, Gallinger Stev
Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review. Journal of Korean medical science 2017 Feb 32 (2): 377-381. Song Won Hoon, Kim Sung Han, Joung Jae Young, Park Weon Seo, Seo Ho Kyung, Chung Jinsoo, Lee Kang Hy
Telomere length is predictive of breast cancer risk in BRCA2 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2017 Feb . Thorvaldsdottir Birna, Aradottir Margret, Stefansson Olafur A, Bodvarsdottir Sigridur K, Eyfjörd Jorunn
[Clinical significance and distribution of BRCA genes mutation in sporadic high grade serous ovarian cancer]. Zhonghua fu chan ke za zhi 2017 Jan 52 (1): 26-31. Liu W L, Wang Z Z, Zhao J Z, Hou Y Y, Wu X X, Li W, Dong B, Tong T T, Guo Y
[Clinical-based study of ovarian cancer patients with and without BRCA1/2 genes mutation: clinical features and pedigree analysis]. Zhonghua fu chan ke za zhi 2017 Jan 52 (1): 20-25. Tao T, Yang J X, Shen K, Cao D
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Journal of the National Cancer Institute 2017 Jan 109 (1): . Kotsopoulos Joanne, Huzarski Tomasz, Gronwald Jacek, Singer Christian F, Moller Pal, Lynch Henry T, Armel Susan, Karlan Beth, Foulkes William D, Neuhausen Susan L, Senter Leigha, Tung Nadine, Weitzel Jeffrey N, Eisen Andrea, Metcalfe Kelly, Eng Charis, Pal Tuya, Evans Gareth, Sun Ping, Lubinski Jan, Narod Steven A,
Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort. Cancer medicine 2017 Jan . Liu Xiaoran, Li Huiping, Shao Bin, Wu Jianmin, Kong Weiyao, Song Guohong, Jiang Hanfang, Wang Jing, Wan Fengli
Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing. Cancer genetics 2017 Jan 210 22-27. Riahi Aouatef, Chabouni-Bouhamed Habiba, Kharrat Mah
[Breast Cancer in Young Women - Correlation of Clinical Histomorphological, and Molecular-genetic Features of Breast Carcinoma in Women Younger than 35 Years of Age]. Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (3): 202-209. Metelková A, Skálová A, Fínek
Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma. Anticancer research 2017 04 37 (4): 1729-1735. Okamoto Tatsuro, Kohno Mikihiro, Ito Kensaku, Takada Kazuki, Katsura Masakazu, Morodomi Yosuke, Toyokawa Gouji, Shoji Fumihiro, Maehara Yoshihi
Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil. BMC cancer 2016 Dec 16 (1): 934. Maistro Simone, Teixeira Natalia, Encinas Giselly, Katayama Maria Lucia Hirata, Niewiadonski Vivian Dionisio Tavares, Cabral Larissa Garcia, Ribeiro Roberto Marques, Gaburo Junior Nelson, de Gouvêa Ana Carolina Ribeiro Chaves, Carraro Dirce Maria, Sabino Ester Cerdeira, Diz Maria Del Pilar Estevez, Chammas Roger, de Bock Geertruida Hendrika, Folgueira Maria Aparecida Azevedo Koi
Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases. JAMA oncology 2016 Dec . Priedigkeit Nolan, Hartmaier Ryan J, Chen Yijing, Vareslija Damir, Basudan Ahmed, Watters Rebecca J, Thomas Roby, Leone Jose P, Lucas Peter C, Bhargava Rohit, Hamilton Ronald L, Chmielecki Juliann, Puhalla Shannon L, Davidson Nancy E, Oesterreich Steffi, Brufsky Adam M, Young Leonie, Lee Adrian
Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer. Oncotarget 2016 Dec 7 (51): 85529-85541. Chao Angel, Chang Ting-Chang, Lapke Nina, Jung Shih-Ming, Chi Peter, Chen Chien-Hung, Yang Lan-Yan, Lin Cheng-Tao, Huang Huei-Jean, Chou Hung-Hsueh, Liou Jui-Der, Chen Shu-Jen, Wang Tzu-Hao, Lai Chyong-Hu
Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients. Current oncology (Toronto, Ont.) 2016 Oct 23 (5): 298-303. Jung J, Kang E, Gwak J M, Seo A N, Park S Y, Lee A S, Baek H, Chae S, Kim E K, Kim S
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-Label Studies. Clinical therapeutics 2016 Oct . Dirix Luc, Swaisland Helen, Verheul Henk M W, Rottey Sylvie, Leunen Karin, Jerusalem Guy, Rolfo Christian, Nielsen Dorte, Molife L Rhoda, Kristeleit Rebecca, Vos-Geelen Judith de, Mau-Sørensen Morten, Soetekouw Patricia, van Herpen Carla, Fielding Anitra, So Karen, Bannister Wendy, Plummer Ru
Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct . Wiesman Chana, Rose Esther, Grant Allison, Zimilover Adam, Klugman Susan, Schreiber-Agus Nico
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. The New England journal of medicine 2016 Oct . Mirza Mansoor R, Monk Bradley J, Herrstedt Jørn, Oza Amit M, Mahner Sven, Redondo Andrés, Fabbro Michel, Ledermann Jonathan A, Lorusso Domenica, Vergote Ignace, Ben-Baruch Noa E, Marth Christian, M?dry Rados?aw, Christensen René D, Berek Jonathan S, Dørum Anne, Tinker Anna V, du Bois Andreas, González-Martín Antonio, Follana Philippe, Benigno Benedict, Rosenberg Per, Gilbert Lucy, Rimel Bobbie J, Buscema Joseph, Balser John P, Agarwal Shefali, Matulonis Ursula A,
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers. British journal of cancer 2016 Oct . Zaaijer Leendert H, van Doorn Helena C, Mourits Marian J E, van Beurden Marc, de Hullu Joanne A, Adank Muriel A, van Lonkhuijzen Luc R C W, Vasen Hans F A, Slangen Brigitte F M, Gaarenstroom Katja N, Zweemer Ronald P, Vencken Peggy M L H, Seynaeve Caroline, Kriege Mie
Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features. BMC women's health 2016 Oct 16 (1): 68. Derkaoui Touria, Bakkach Joaira, Mansouri Mohamed, Loudiyi Ali, Fihri Mohamed, Alaoui Fatima Zahra, Barakat Amina, El Yemlahi Bouchra, Bihri Hassan, Nourouti Naima Ghailani, Mechita Mohcine Benna
BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis. Oncotarget 2016 Sep . Zhu Yaning, Wu Jian, Zhang Chengwan, Sun Suan, Zhang Jian, Liu Wenjie, Huang Jian, Zhang Zhiho
BRCA Share: A Collection of Clinical BRCA Gene Variants. Human mutation 2016 Sep . Beroud Christophe, Letovsky Stanley I, Braastad Corey D, Caputo Sandrine M, Beaudoux Olivia, Bignon Yves Jean, De Paillerets Brigitte Bressac-, Bronner Myriam, Buell Crystal M, Collod-Béroud Gwenaëlle, Coulet Florence, Derive Nicolas, Divincenzo Christina, Elzinga Christopher D, Garrec Céline, Houdayer Claude, Karbassi Izabela, Lizard Sarab, Love Angela, Muller Danièle, Nagan Narasimhan, Nery Camille R, Rai Ghadi, Revillion Françoise, Salgado David, Sévenet Nicolas, Sinilnikova Olga, Sobol Hagay, Stoppa-Lyonnet Dominique, Toulas Christine, Trautman Edwin, Vaur Dominique, Vilquin Paul, Weymouth Katelyn S, Willis Alecia, , , , Eisenberg Marcia, Strom Charles
Cardiovascular risk of BRCA1/2 mutation carriers: A review. Maturitas 2016 Sep 91 135-9. van Westerop L L M, Arts-de Jong M, Hoogerbrugge N, de Hullu J A, Maas A H E
Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes Among Korean Breast Cancer Patients. Cancer research and treatment : official journal of Korean Cancer Association 2016 Sep . Yoon Kyong-Ah, Park Boyoung, Lee Byung Il, Yang Moon Jung, Kong Sun-Young, Lee Eun So
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nature genetics 2016 Sep . Secrier Maria, Li Xiaodun, de Silva Nadeera, Eldridge Matthew D, Contino Gianmarco, Bornschein Jan, MacRae Shona, Grehan Nicola, O'Donovan Maria, Miremadi Ahmad, Yang Tsun-Po, Bower Lawrence, Chettouh Hamza, Crawte Jason, Galeano-Dalmau Núria, Grabowska Anna, Saunders John, Underwood Tim, Waddell Nicola, Barbour Andrew P, Nutzinger Barbara, Achilleos Achilleas, Edwards Paul A W, Lynch Andy G, Tavaré Simon, Fitzgerald Rebecca C,
Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers. Gynecologic oncology 2016 Sep . Zakhour Mae, Danovitch Yael, Lester Jenny, Rimel B J, Walsh Christine S, Li Andrew J, Karlan Beth Y, Cass Ila
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet. Oncology 2016 Sep . Ledermann Jonathan A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Rowe Philip, Lowe Elizabeth, Hodgson Darren, Sovak Mika A, Matulonis Ursu
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations. Cancer genetics 2016 Sep 209 (9): 417-422. Alemar Bárbara, Herzog Josef, Brinckmann Oliveira Netto Cristina, Artigalás Osvaldo, Schwartz Ida Vanessa D, Matzenbacher Bittar Camila, Ashton-Prolla Patricia, Weitzel Jeffrey
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk. Journal of adolescent and young adult oncology 2016 Aug . Giordano Sara, Garrett-Mayer Elizabeth, Mittal Navdha, Smith Kristin, Shulman Lee, Passaglia Carolyn, Gradishar William, Pavone Mary Ell
BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype. Journal of gastrointestinal oncology 2016 Aug 7 (4): 556-61. Al-Shamsi Humaid O, Anand Deepa, Shroff Rachna T, Jain Apurva, Zuo Mingxin, Conrad Claudius, Vauthey Jean-Nicolas, Javle Milind
First application of next-generation sequencing in Moroccan breast/ovarian cancer families and report of a novel frameshift mutation of the BRCA1 gene. Oncology letters 2016 Aug 12 (2): 1192-1196. Jouali Farah, Laarabi Fatima-Zahra, Marchoudi Nabila, Ratbi Ilham, Elalaoui Siham Chafai, Rhaissi Houria, Fekkak Jamal, Sefiani Abdelaz
Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma. Gynecologic oncology 2016 Aug . Morse Christopher B, Norquist Barbara M, Harrell Maria I, Agnew Kathy J, Gray Heidi J, Urban Renata R, Garcia Rochelle L, Goff Barbara A, Swisher Elizabeth
Next-Generation Sequencing of Tumors to Better Estimate the Clinical Significance of Non-BRCA Germline Deleterious Mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Aug . Sorscher Steven
Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study. The American journal of clinical nutrition 2016 Jul . Kim Shana J, Zuchniak Anna, Sohn Kyoung-Jin, Lubinski Jan, Demsky Rochelle, Eisen Andrea, Akbari Mohammad R, Kim Young-In, Narod Steven A, Kotsopoulos Joan
Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice. Oncotarget 2016 Jul . Solano Angela Rosaria, Cardoso Florencia Cecilia, Romano Vanesa, Perazzo Florencia, Bas Carlos, Recondo Gonzalo, Santillan Francisco Bernardo, Gonzalez Eduardo, Abalo Eduardo, Viniegra María, Michel José Davalos, Nuñez Lina María, Noblia Cristina Maria, Mc Lean Ignacio, Canton Enrique Diaz, Chacon Reinaldo Daniel, Cortese Gustavo, Varela Eduardo Beccar, Greco Martín, Barrientos María Laura, Avila Silvia Adela, Vuotto Hector, Lorusso Antonio, Podesta Ernesto Jorge, Mando Oscar Gasp
[BRCA1/2 gene mutation and clinicopathologic features of triple negative breast cancer]. Zhonghua bing li xue za zhi Chinese journal of pathology 2016 Jun 45 (6): 397-400. Ma Z P, Wang W, Zhang
A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial. Future oncology (London, England) 2016 Jun . Roviello Giandomenico, Milani Manuela, Gobbi Angela, Dester Martina, Cappelletti Maria Rosa, Allevi Giovanni, Aguggini Sergio, Ravelli Andrea, Gussago Francesca, Cocconi Alessandra, Zanotti Laura, Senti Chiara, Strina Carla, Bottini Alberto, Generali Danie
Bias explains most of the parent-of-origin effect on breast cancer risk in BRCA1/2 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2016 Jun . Vos Janet R, Oosterwijk Jan C, Aalfs Cora M, Rookus Matti A, Adank Muriel A, van der Hout Annemarie H, van Asperen Christi J, Gomez-Garcia Encarna B, Mensenkamp Arjen R, Jager Agnes, Ausems Margreet G E M, Mourits Marian J, de Bock Geertruida
Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer. Annals of surgical oncology 2016 Jun . Murphy Brittany L, Hoskin Tanya L, Boughey Judy C, Degnim Amy C, Glazebrook Katrina N, Hieken Tina
Do BRCA1/2 mutation carriers have an earlier onset of natural menopause? Menopause (New York, N.Y.) 2016 Jun . van Tilborg Theodora C, Broekmans Frank J, Pijpe Anouk, Schrijver Lieske H, Mooij Thea M, Oosterwijk Jan C, Verhoef Senno, Gómez Garcia Encarna B, van Zelst-Stams Wendy A, Adank Muriel A, van Asperen Christi J, van Doorn Helena C, van Os Theo A, Bos Anna M, Rookus Matti A, Ausems Margreet
Genetic testing for hereditary breast cancer in Asia-moving forward. Chinese clinical oncology 2016 Jun 5 (3): 47. Kwong A
Germline Mutations in DNA Repair Genes May Predict Neoadjuvant Therapy Response in Triple Negative Breast Patients. Genes, chromosomes & cancer 2016 Jun . Spugnesi Laura, Gabriele Michele, Scarpitta Rosa, Tancredi Mariella, Maresca Luisa, Gambino Gaetana, Collavoli Anita, Aretini Paolo, Bertolini Ilaria, Salvadori Barbara, Landucci Elisabetta, Fontana Andrea, Rossetti Elena, Roncella Manuela, Naccarato Giuseppe Antonio, Caligo Maria Adelai
Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes. Anticancer research 2016 Jun 36 (6): 3185-90. Kolben Thomas, Hary Thomas, Holdt Lesca M, Schwarz Theresa M, Goess Christine, Wuerstlein Rachel, Gallwas Julia, Toth Bettina, Weissenbacher Tobias, Jeschke Udo, Harbeck Nadia, Ditsch Ni
Detection of Human Papillomavirus Genotypes and Major BRCA Mutations in Familial Breast Cancer. Monoclonal antibodies in immunodiagnosis and immunotherapy 2016 May . Mohtasebi Parinaz, Rassi Hossein, Maleki Fatemeh, Hajimohammadi Sameh, Bagheri Zahra, Fakhar Miandoab Malihe, Naserbakht Mahdi
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations. Breast cancer research and treatment 2016 May . Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, Hendler D, Neiman V, Ben-Aharon I, Friedman E, Paluch-Shimon S, Margel D, Kedar I, Yerushalmi
Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. British journal of cancer 2016 May . Drew Yvette, Ledermann Jonathan, Hall Geoff, Rea Daniel, Glasspool Ros, Highley Martin, Jayson Gordon, Sludden Julieann, Murray James, Jamieson David, Halford Sarah, Acton Gary, Backholer Zoe, Mangano Raffaella, Boddy Alan, Curtin Nicola, Plummer Ru
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Bone marrow transplantation 2016 Apr . Boudin L, Gonçalves A, Sabatier R, Moretta J, Sfumato P, Asseeva P, Livon D, Bertucci F, Extra J-M, Tarpin C, Houvenaegel G, Lambaudie E, Tallet A, Resbeut M, Sobol H, Charafe-Jauffret E, Calmels B, Lemarie C, Boher J-M, Viens P, Eisinger F, Chabannon
Identification of Novel BRCA Founder Mutations in Middle Eastern Breast Cancer Patients Using Capture and Sanger Sequencing Analysis. International journal of cancer 2016 Apr . Bu Rong, Siraj Abdul K, Al-Obaisi Khadija A S, Beg Shaham, Al Hazmi Mohsen, Ajarim Dahish, Tulbah Asma, Al-Dayel Fouad, Al-Kuraya Khawla
Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study. European journal of internal medicine 2016 Apr . Azzollini Jacopo, Scuvera Giulietta, Bruno Eleonora, Pasanisi Patrizia, Zaffaroni Daniela, Calvello Mariarosaria, Pasini Barbara, Ripamonti Carla B, Colombo Mara, Pensotti Valeria, Radice Paolo, Peissel Bernard, Manoukian Siranou
Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. Cancer 2016 Apr . Matulonis Ursula A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Parry David, Grinsted Lynda, Ledermann Jonathan
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families. Breast cancer (Tokyo, Japan) 2016 Mar . Riahi Aouatef, Ghourabi Mohamel El, Fourati Asma, Chaabouni-Bouhamed Habi
Molecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriers. Oncotarget 2016 Mar . Benitez-Buelga Carlos, Vaclová Tereza, Ferreira Sofia, Urioste Miguel, Inglada-Perez Lucia, Soberón Nora, Blasco Maria A, Osorio Ana, Benitez Javi
BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population. Familial cancer 2016 Feb . Nielsen Henriette Roed, Nilbert Mef, Petersen Janne, Ladelund Steen, Thomassen Mads, Pedersen Inge Søkilde, Hansen Thomas V O, Skytte Anne-Bine, Borg Åke, Therkildsen Christi
Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis. British journal of cancer 2016 Feb . Phi Xuan-Anh, Saadatmand Sepideh, De Bock Geertruida H, Warner Ellen, Sardanelli Francesco, Leach Martin O, Riedl Christopher C, Trop Isabelle, Hooning Maartje J, Mandel Rodica, Santoro Filippo, Kwan-Lim Gek, Helbich Thomas H, Tilanus-Linthorst Madeleine Ma, van den Heuvel Edwin R, Houssami Nehm
Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens. Breast cancer research and treatment 2016 Feb 155 (3): 597-601. Evans D G, Lalloo F, Howell S, Verhoef S, Woodward E R, Howell
Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis. Familial cancer 2016 Feb . Sabatier Renaud, Lavit Elise, Moretta Jessica, Lambaudie Eric, Noguchi Tetsuro, Eisinger François, Cherau Elisabeth, Provansal Magali, Livon Doriane, Rabayrol Laetitia, Popovici Cornel, Charaffe-Jauffret Emmanuelle, Sobol Hagay, Viens Patri
Prevalence and spectrum of BRCA germline variants in mainland Chinese familial breast and ovarian cancer patients. Oncotarget 2016 Feb . Kim Yeong C, Zhao Linli, Zhang Hanwen, Huang Ye, Cui Jian, Xiao Fengxia, Downs Bradley, Wang San Mi
Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer (HBOC) Genes in Patients Lacking known BRCA Mutations. Human mutation 2016 Feb . Caminsky Natasha G, Mucaki Eliseos J, Perri Ami M, Lu Ruipeng, Knoll Joan H M, Rogan Peter
Twenty-one-gene recurrence score assay in BRCA-associated versus sporadic breast cancers: Differences based on germline mutation status. Cancer 2016 Feb . Shah Payal D, Patil Sujata, Dickler Maura N, Offit Kenneth, Hudis Clifford A, Robson Mark
Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016 Jan . Moreno L, Linossi C, Esteban I, Gadea N, Carrasco E, Bonache S, Gutiérrez-Enríquez S, Cruz C, Díez O, Balmaña
KOHBRA BRCA risk calculator (KOHCal): a model for predicting BRCA1 and BRCA2 mutations in Korean breast cancer patients. Journal of human genetics 2016 Jan . Kang Eunyoung, Park Sue K, Lee Jong Won, Kim Zisun, Noh Woo-Chul, Jung Yongsik, Yang Jung-Hyun, Jung Sung Hoo, Kim Sung-W
Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer. Oncotarget 2016 Jan . Lin Po-Han, Kuo Wen-Hung, Huang Ai-Chu, Lu Yen-Shen, Lin Ching-Hung, Kuo Sung-Hsin, Wang Ming-Yang, Liu Chun-Yu, Cheng Fiona Tsui-Fen, Yeh Ming-Hsin, Li Huei-Ying, Yang Yu-Hsuan, Hsu Yu-Hua, Fan Sheng-Chih, Li Long-Yuan, Yu Sung-Liang, Chang King-Jen, Chen Pei-Lung, Ni Yen-Hsuan, Huang Chiun-She
Assessing biases of information contained in pedigrees for the classification of BRCA-genetic variants: a study arising from the ENIGMA analytical working group. Hereditary cancer in clinical practice 2016 14 10. Kerkhofs C H H, Spurdle A B, Lindsey P J, Goldgar D E, Gómez-García E
BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study. Journal of ovarian research 2016 9 (1): 18. Unni Sudhir K, Schauerhamer Marisa B, Deka Rishi, Tyczynski Jerzy E, Fernandes Ancilla W, Stevens Vanessa, Brixner Diana I, Stenehjem David
BRCA1 Gene Mutations and Influence of Chemotherapy on Autophagy and Apoptotic Mechanisms in Egyptian Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2016 17 (3): 1285-92. Abdel-Mohsen Mohamed Ahmed, Ahmed Omiama Ali, El-Kerm Yasser Mosta
Clinical and pathological features of BRCA1/2 tumors in a sample of high-risk Moroccan breast cancer patients. BMC research notes 2016 9 (1): 248. Jouhadi Hassan, Tazzite Amal, Azeddoug Houssine, Naim Asmâa, Nadifi Sellama, Benider Abdellat
Comparison of effectiveness of treatment of patients with sporadic and germline BRCA1-related ovarian cancer. Ginekologia polska 2016 87 (6): 422-5. Szatkowski Wiktor, Muzykiewicz Konrad, Jasiówka Marek, Karolewski Kazimierz, Kojs Zbigiew, Klimek Ma?gorzata, Blecharz Paw
Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers. Frontiers in oncology 2016 6 92. Cui Jian, Luo Jiangtao, Kim Yeong C, Snyder Carrie, Becirovic Dina, Downs Bradley, Lynch Henry, Wang San Mi
Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing. Frontiers in genetics 2016 7 71. Elsayegh Nisreen, Barrera Angelica M Gutierrez, Muse Kimberly I, Lin Heather, Kuerer Henry M, Helm Monica, Litton Jennifer K, Arun Banu
Frequency and Significance of Abnormal Pancreatic Imaging in Patients with BRCA1 and BRCA2 Genetic Mutations. Scientifica 2016 2016 5619358. Chahla Elie, Cheesman Antonio, Mahon Suzanne M, Garrett Robert W, Bradenham Ben P, Schwartz Theresa L, Omran Louay, Taylor Jason R, Alkaade Sam
Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression. PloS one 2016 11 (5): e0154789. Templeton Arnoud J, Gonzalez Laura Diez, Vera-Badillo Francisco E, Tibau Ariadna, Goldstein Robyn, Šeruga Boštjan, Srikanthan Amirrtha, Pandiella Atanasio, Amir Eitan, Ocana Alber
Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC cancer 2016 16 (1): 375. Gargiulo Piera, Pensabene Matilde, Milano Monica, Arpino Grazia, Giuliano Mario, Forestieri Valeria, Condello Caterina, Lauria Rossella, De Placido Sabi
Mutation Spectra of BRCA Genes in Iranian Women with Early Onset Breast Cancer - 15 Years Experience. Asian Pacific journal of cancer prevention : APJCP 2016 17 Spec No. 149-53. Yassaee Vahid Reza, Ravesh Zeinab, Soltani Ziba, Hashemi-Gorji Feyzollah, Poorhosseini Seyed Mohammad, Anbiaee Robab, Joulaee Azad
Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival. Ecancermedicalscience 2016 10 639. Biglia Nicoletta, Sgandurra Paola, Bounous Valentina Elisabetta, Maggiorotto Furio, Piva Eleonora, Pivetta Emanuele, Ponzone Riccardo, Pasini Barba
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy. BMC medical genetics 2016 17 (1): 11. Cini Giulia, Mezzavilla Massimo, Della Puppa Lara, Cupelli Elisa, Fornasin Alessio, D'Elia Angela Valentina, Dolcetti Riccardo, Damante Giuseppe, Bertok Sara, Miolo Gianmaria, Maestro Roberta, de Paoli Paolo, Amoroso Antonio, Viel Alessand
Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study. Acta bio-medica : Atenei Parmensis 2016 87 (1): 54-63. Pellegrino Benedetta, Bella Mariangela, Michiara Maria, Zanelli Paola, Naldi Nadia, Porzio Rosa, Bortesi Beatrice, Boggiani Daniela, Zanoni Daniele, Camisa Roberta, Neri Tauro Maria, Pinto Carmine, Musolino Antoni
[Germline mutations of TP53 gene among Chinese families with high risk for breast cancer]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015 Dec 32 (6): 761-5. Yang Xiaochen, Hu Zhen, Wu Jiong, Liu Guangyu, Di Genhong, Chen Canming, Hou Yifeng, Huang Xiaoyan, Liu Zhebin, Shen Zhenzhou, Shao Zhim
Decreased Expression of BRCA2 Accelerates Sporadic Breast Cancer Progression. Indian journal of surgical oncology 2015 Dec 6 (4): 378-83. Saha Soumi, Mandal Pranab, Ganguly Suvro, Jana Debarshi, Ayaz Asif, Banerjee Abhirup, Chouhan Rahul, Sarkar Diptendra Kum
PROSPECTIVE PHASE II TRIAL OF TRABECTEDIN IN BRCA MUTATED AND/OR BRCAness PHENOTYPE RECURRENT OVARIAN CANCER PATIENTS: THE MITO 15 TRIAL. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Dec . Lorusso D, Scambia G, Pignata S, Sorio R, Amadio G, Lepori S, Mosconi A, Pisano C, Mangili G, Maltese G, Sabbatini R, Artioli G, Gamucci T, Di Napoli M, Capoluongo E, Ludovini V, Raspagliesi F, Ferrandina
Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis. Familial cancer 2015 Dec . de Oliveira Eneida Santos, Soares Bárbara Luisa, Lemos Sara, Rosa Reginaldo Cruz Alves, Rodrigues Angélica Nogueira, Barbosa Leandro Augusto, de Oliveira Lopes Débora, Dos Santos Luciana La
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertility and sterility 2015 Dec . Gronwald Jacek, Glass Karen, Rosen Barry, Karlan Beth, Tung Nadine, Neuhausen Susan L, Moller Pal, Ainsworth Peter, Sun Ping, Narod Steven A, Lubinski Jan, Kotsopoulos Joanne,
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer. Journal of cancer research and clinical oncology 2015 Nov 141 (11): 2005-12. Muendlein Axel, Rohde Bettina H, Gasser Klaus, Haid Anton, Rauch Stephanie, Kinz Elena, Drexel Heinz, Hofmann Wera, Schindler Verena, Kapoor Rita, Decker Thomas, Lang Alois
Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes. The American journal of surgical pathology 2015 Nov . Hussein Yaser R, Ducie Jennifer A, Arnold Angela G, Kauff Noah D, Vargas-Alvarez Hebert A, Sala Evis, Levine Douglas A, Soslow Robert
Ten-year survival after epithelial ovarian cancer is not associated with BRCA mutation status. Gynecologic oncology 2015 Nov . Kotsopoulos Joanne, Rosen Barry, Fan Isabel, Moody Joel, McLaughlin John R, Risch Harvey, May Taymaa, Sun Ping, Narod Steven
Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 2015 Oct 35 (5): 629-34. Shao Jun, Yang Jie, Wang Jun-Nai, Qiao Long, Fan Wei, Gao Qing-Lei, Feng Yao-J

Public Health Genomics Knowledge Base (v2.0)

HuGE Literature Finder

File Formats Help: